Upgrade to premium
Regulatory bioequivalence gives you access to the marketplace, but not the means to dominate it. Your biosimilar needs an exclusive differentiator that aligns exactly with what the end-user wants. It needs to be premium.
Premium biosimilars provide the differentiators you need to gain a competitive edge in the marketplace while remaining bioequivalent. They can also be tailor-made to match your exact requirements, with patent protection to prevent the competition from following your lead.
Phenotypeca’s unique QTL technology is the key to creating, customising and manufacturing premium biosimilars. QTL technology enables us to breed, screen and optimise strains to meet multi-parameter specifications that are beyond the reach of standard methods. Our process unlocks the power of the entire strain genome resulting in a patent protected optimal strain.
What happens next
Have you identified an exciting market opportunity for a premium biosimilar – but are concerned about access to a viable means of manufacture? Perhaps you’ve considered creating your own biosimilar by standard means, but worry that rivals will have a competitive edge to prevent you from gaining market share.
Together we can go over your commercial objectives and evaluate how we can customise a swift, affordable and patent protected strain that is ready for manufacturing at scale and that is licensed exclusively to you.